DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Brodsky RA, Young NS, Antonioli E. et al.
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
Blood 2008;
111: 1840-1847.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.